The Effect of Eicosapentaenoic Acid Supplementation on Depression Remission: a Double-Blind Randomized Clinical Trial
Introduction: There is some evidence that omega-3 fatty acids are associated with depression. The aim of this study was to compare the effects of eicosapentaenoic acid(EPA) and placebo on mild to moderate depression. Methods: This double-blind randomized clinical trial was conducted on 54 outpatient...
Main Authors: | Karamati, Yassini-Ardakani, Mozaffari-Khosrav, Shariati-Bafghi, Fallahzadeh |
---|---|
Format: | Article |
Language: | fas |
Published: |
Shahid Sadoughi University of Medical Sciences
2011-12-01
|
Series: | Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd |
Subjects: | |
Online Access: | http://85.185.157.11:6280/jssu/browse.php?a_id=1744&slc_lang=en&sid=1&ftxt=1 |
Similar Items
-
Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
by: Fraser D. Russell, et al.
Published: (2012-11-01) -
Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga <i>Nannochloropsis</i> Decreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized, Placebo-Controlled, Three-Month Supplementation Study
by: Amanda Rao, et al.
Published: (2020-06-01) -
The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
by: Martin F. Reiner, et al.
Published: (2021-02-01) -
Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells
by: Kembra Albracht-Schulte, et al.
Published: (2019-03-01) -
The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
by: Jacqueline K. Innes, et al.
Published: (2018-02-01)